NVLN

Novelion Therapeutics Inc. Common Shares
NVLN

Overview Fund Activity
Delisted

NVLN was delisted on the 8th of October, 2019.

Back to rankings

82 hedge funds and large institutions have $47.1M invested in Novelion Therapeutics Inc. Common Shares in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+10
Holders Change %
+13.89%
% of All Funds
1.86%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
16
Increased
25
Reduced
12
Closed
6
Calls
$50K
Puts
$103K
Net Calls
-$53K
Net Calls Change
+$576K

Top Buyers

1
EIG
EdgePoint Investment Group
Ontario, Canada
+$3.6M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$749K
3
HVC
Healthcare Value Capital
New Jersey
+$370K
4
State Street
State Street
Massachusetts
+$229K
5
Morgan Stanley
Morgan Stanley
New York
+$220K

Top Sellers

1
HCM
Highbridge Capital Management
New York
-$6.03M
2
SCM
Stonepine Capital Management
Oregon
-$411K
3
AA
Ancora Advisors
Ohio
-$361K
4
LCS
Levin Capital Strategies
New York
-$334K
5
CS
Credit Suisse
Switzerland
-$225K
Name Holding Trade Value Shares
Change 		Shares
Change %
NFA
76
Nationwide Fund Advisors
Ohio
– -$58K -8,311 Closed
AG
77
Advisor Group
Arizona
– -$4K -594 Closed
Toronto Dominion Bank
78
Toronto Dominion Bank
Ontario, Canada
– -$3K -400 Closed
1 2 3
4